Core Viewpoint - The 19th China Scientific Instrument Development Annual Conference (ACCSI2026) will be held from April 22-24, 2026, in Beijing, focusing on the theme "AI Empowerment, Smart Future" to promote the intelligent transformation of the scientific instrument industry in China [1][2]. Group 1: Conference Overview - The conference aims to build a high-end communication platform for government, industry, academia, research, application, investment, and media, and has been recognized as the "Davos Forum" for the scientific instrument industry, with over 1,500 attendees in previous editions [1][2]. - The event will summarize the latest developments in the Chinese scientific instrument industry over the past year, including industry policies, market demands, and technological advancements [1]. Group 2: Awards and Recognition - During the conference, the "3i Award: Instrument and Testing Wind and Cloud List Award Ceremony" will be held, presenting multiple annual industry awards such as "2025 Excellent New Product" and "2025 Green Instrument" [2]. Group 3: Organizing Institutions - The conference is organized by Instrument Information Network and the Zhongguancun Science City Management Committee, with support from various associations and institutions, including the China Analysis Testing Association and the Beijing High-end Scientific Instrument Technology Innovation Center [3][4]. Group 4: Conference Scale and Venue - The conference is expected to host around 1,500 participants and will take place at the Langliz West Mountain Garden Hotel in Haidian District, Beijing [6]. Group 5: Agenda Highlights - The agenda includes various forums and keynote speeches focusing on AI strategies, market trends, and innovations in scientific instruments, featuring prominent speakers from leading companies and institutions [6][7][9][12]. - Specific topics include AI's impact on scientific instruments, market behavior analysis, and the development of local ecosystems for scientific instruments [6][7][9]. Group 6: Target Audience - The main attendees will include executives from instrument manufacturers, government officials, heads of testing institutions, laboratory leaders, and representatives from investment institutions and media [19]. Group 7: Registration and Participation - Registration details indicate different ticket types, with VIP tickets priced at 2,500 yuan and regular tickets at 1,500 yuan, offering various benefits such as access to all forums and conference materials [20].

Core Viewpoint - The core proposition of domestic liquid chromatography has evolved from "can it be used" to "can it perform well in high-demand scenarios" as domestic scientific instruments accelerate their rise [2][4]. Group 1: Company Development - Since its establishment in 2015, Huapu Science Instrument (Beijing) Technology Co., Ltd. has completed the transition from self-research of instruments to a full industry chain layout, launching new products including the S6000 ULTRA ultra-high-performance liquid chromatography system and the Chromolong 3.0 chromatography information management system [2][5]. - Over the past ten years, Huapu has focused on the localization of core technologies, continuously advancing its product and capability system, with breakthroughs in five key technology areas: ultra-high pressure fluid systems, high-performance chromatography fillers, high-sensitivity detectors, intelligent management software, and precision manufacturing and supply chain integration [5][6]. Group 2: Product and Technology - The latest ultra-high-performance liquid chromatography system (UHPLC) S6000 ULTRA emphasizes not just achieving high pressure but maintaining long-term stable operation in the 120-150 MPa range, with over 95% localization of components [6][7]. - Huapu has developed a complete ecosystem for domestic chromatography consumables, offering products with comprehensive species types, stable bonding technology, and high batch consistency, exemplified by the popular Niuhuang column included in the 2025 edition of the Chinese Pharmacopoeia [7]. Group 3: Service and Market Trust - Huapu has built a comprehensive service system encompassing "instruments-software-consumables-after-sales-application," addressing past concerns about the reliability of domestic liquid chromatography instruments and the adequacy of application support [9][10]. - The company has successfully bid for 33 high-efficiency liquid chromatography instruments in the 2025 Customs procurement project, marking a significant validation of its ecosystem capabilities and enhancing customer trust in domestic brands [10]. Group 4: Future Development - Looking ahead to 2026, Huapu plans to increase investment in key core technology breakthroughs and enhance software capabilities in compliance, data security, and adaptation to domestic operating systems, while expanding solutions for more application scenarios through collaboration and automation [12][14].

Investment Rating - The investment rating for Haineng Technology (920476.BJ) is "Buy" (maintained) [1] Core Views - The company reported a revenue of 362 million yuan for 2025, representing a year-on-year growth of 16.63%. The net profit attributable to shareholders was 42.13 million yuan, a significant increase of 222.30% year-on-year. The non-recurring net profit reached 35.59 million yuan, up 821.71% year-on-year [4] - The company is expected to maintain strong growth, with projected net profits for 2026-2028 at 53 million yuan, 64 million yuan, and 81 million yuan respectively, corresponding to EPS of 0.62, 0.75, and 0.95 yuan per share. The current price-to-earnings ratios are 34.0, 28.2, and 22.1 times [4] - The company has launched high-end products and is actively upgrading existing products to enhance competitiveness in both domestic and international markets [5] Financial Summary - For 2025, the company achieved a revenue of 362 million yuan, with a year-on-year growth of 16.63%. The net profit attributable to shareholders was 42.13 million yuan, reflecting a year-on-year increase of 222.30% [4][10] - The company’s revenue is projected to grow to 434 million yuan in 2026, 499 million yuan in 2027, and 606 million yuan in 2028, with corresponding net profits of 53 million yuan, 64 million yuan, and 81 million yuan [9][10] - The gross margin is expected to remain stable around 65%, with net margins improving from 10.7% in 2025 to 12.9% in 2028 [10]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a revenue of 362 million yuan for 2025, representing a year-on-year growth of 16.63%, and a net profit attributable to shareholders of 42.13 million yuan, which is a significant increase of 222.30% year-on-year [4] - The company is expected to maintain strong growth, with projected net profits for 2026-2028 at 53 million yuan, 64 million yuan, and 81 million yuan respectively, corresponding to EPS of 0.62, 0.75, and 0.95 yuan per share [4] - The company is actively engaged in the development of high-end scientific instruments and has made significant advancements in product automation and intelligence [5][6] Financial Summary - Revenue is projected to grow from 362 million yuan in 2025 to 434 million yuan in 2026, 499 million yuan in 2027, and 606 million yuan in 2028, with respective year-on-year growth rates of 19.9%, 14.9%, and 21.4% [9] - The gross margin is expected to remain stable, with estimates of 65.1% in 2026, 64.9% in 2027, and 65.5% in 2028 [10] - The net profit margin is projected to improve from 10.7% in 2025 to 10.6% in 2026, 11.9% in 2027, and 12.9% in 2028 [10] - The company has maintained a strong return on equity (ROE), expected to rise from 8.7% in 2025 to 9.4% in 2026, 11.0% in 2027, and 12.8% in 2028 [10] Product Development and Market Position - The company launched the high-end N70 Fourier Transform Near-Infrared Spectrometer in September 2025, which is applicable in various fields such as pharmaceuticals, chemicals, and food [5] - The company has invested 54.11 million yuan in R&D, accounting for 14.96% of its revenue, and has obtained 15 new invention patents and 11 utility model patents [6] - The company is focusing on domestic high-demand sectors and international high-end markets, enhancing its competitive edge through product innovation and automation [5][6]

Core Viewpoint - The "Innovation 100" project aims to empower small and medium-sized enterprises (SMEs) in the domestic scientific instrument industry through various services, fostering innovation and growth in critical development phases [1][2]. Group 1: Project Overview - The "Innovation 100" initiative, launched in 2018, has attracted over 300 participating companies and conducted visits to more than 130 enterprises, providing a rich platform for communication and collaboration [2]. - The project serves as a public welfare initiative, utilizing member services, reporting, visits, research and learning activities, and evaluations to support SMEs in the scientific instrument sector [2]. Group 2: Application Process - The application for the 2026 "Innovation 100" program has officially begun, with free registration available for eligible companies [3]. - Eligibility criteria include being a manufacturer of scientific instruments or related consumables, having an annual output value of less than 50 million yuan, and meeting specific innovation capability requirements [4]. Group 3: Services Offered - The project provides various services, including full-site display on the "Innovation 100" section of the Instrument Information Network, enterprise publicity through articles, resource matching via offline study classes, and participation in annual potential enterprise evaluations [5]. Group 4: Registration Details - Companies interested in applying must fill out an application form and send it to the specified email address, with the application period outlined in the article [7].

Core Viewpoint - Shanghai Jingxin's two instruments have been selected as "Good Domestic Instruments," focusing on user needs, overcoming technical bottlenecks, and serving fields such as biomedicine, disease control monitoring, and scientific research testing, thereby promoting the high-quality development of domestic instruments [1][2]. Group 1: Company Background - Shanghai Jingxin has over ten years of experience in the scientific instrument industry, adhering to the principles of "serving the country and the people" and "user satisfaction is the true measure of quality" [4]. - The "Good Domestic Instruments" project has been developing for 12 years, aiming to identify and promote excellent instrument products and brands to enhance the reputation of domestic instruments [2]. Group 2: Characteristics of Good Instruments - Good instruments are defined by four core characteristics: performance as the foundation, adaptability as the value, reliability and practicality as the baseline, and user-friendly service as the original intention [5][6]. - The focus is on overcoming technical bottlenecks and ensuring that instruments meet critical user needs while being cost-effective and accessible to grassroots and small enterprises [6]. Group 3: Product Development and Innovation - The selected products, the Vacuum Centrifuge Concentrator JX-ZLN-EL and the Frozen Grinding Instrument JXFSTPRP-CLN, were developed based on user needs and aimed at addressing key pain points in the industry [7]. - The Frozen Grinding Instrument addresses issues such as insufficient low-temperature capability and safety risks, allowing for the simultaneous processing of 192 samples, significantly improving efficiency [9]. - The Vacuum Centrifuge Concentrator enhances the recovery rate of nucleic acid samples to over 95% and reduces processing time to 1-3 hours, meeting the efficiency and activity requirements of pharmaceutical companies [10]. Group 4: User Recognition and Service - The recognition of the products is attributed to the company's commitment to integrity and service, ensuring rigorous quality control and responsive local service mechanisms [11][12]. - High scores in cost-effectiveness and service detail in the "Good Domestic Instruments" evaluation reflect the company's strong technical capabilities and customer-oriented approach [12]. Group 5: Application Areas and Industry Impact - The two selected products are utilized in various critical fields, including biomedicine, disease control monitoring, and scientific research, addressing specific needs such as sample preservation and efficient purification [13][14]. - The combination of these products creates a complete workflow from sample preparation to target substance purification, supporting advancements in biomedicine and emergency monitoring [14][16]. Group 6: Industry Challenges and Future Outlook - While domestic instruments have advantages such as understanding local needs and providing efficient service, challenges remain in high-end components and brand influence [20]. - The company aims to align with national strategies, enhance public health emergency applications, and support green development and rural revitalization, while also striving to become a benchmark platform for innovation in the scientific instrument sector [19][21][22].

Group 1: Economic Data Overview - In January-February 2026, the year-on-year growth of social retail sales was +2.8%, an increase of 1.9 percentage points compared to December 2025, but a decrease of 0.89 percentage points compared to the entire year of 2025 [6][7] - Fixed asset investment (FAI) in January-February 2026 showed a year-on-year increase of +1.8%, recovering from a decline of -3.8% in 2025, primarily driven by strong infrastructure investment [8][9] - The industrial added value for large-scale enterprises increased by +6.3% year-on-year in January-February 2026, marking a significant acceleration compared to December 2025 [10][11] Group 2: Banking Sector Insights - The banking sector is experiencing a new normal of "quality over quantity" in credit growth, with a projected loan growth rate of around 6.0% for 2026, influenced by fiscal policies and a focus on supported industries [14][15] - Profitability in the banking sector is stabilizing, with retail risks still present but manageable; large state-owned banks are expected to maintain dividend value due to low valuations [16][17] - Investment strategies should focus on two main lines: banks with strong wealth management capabilities and low valuation targets, as well as city and rural commercial banks with controllable risks and strong profit certainty [17] Group 3: Jiangsu Bank Analysis - Jiangsu Bank, a leading city commercial bank in the Yangtze River Delta, holds a significant market share in loans and deposits within Jiangsu province, with a loan balance accounting for 7.23% of the province's total [19][20] - The bank's corporate lending is supported by strong demand in manufacturing and infrastructure, while retail lending is steadily growing, particularly in consumer loans [20][21] - Jiangsu Bank's financial performance is robust, with a return on equity (ROE) significantly higher than the industry average, and a declining non-performing loan ratio of 0.84% [22][23] Group 4: HaiNeng Technology Overview - HaiNeng Technology reported a revenue of 362 million yuan in 2025, a year-on-year increase of 16.63%, with a net profit of 42.13 million yuan, reflecting a substantial growth in profitability [25][26] - The company is expanding its product lines in high-end scientific instruments, with significant growth in sample preparation and chromatography products, and is expected to continue this trend in 2026 [26][27] - HaiNeng Technology emphasizes shareholder returns, planning to distribute a cash dividend of 1.00 yuan per 10 shares, alongside a share buyback of 348,900 shares [30]

Core Viewpoint - The situation in the Strait of Hormuz significantly impacts the supply chain of helium and specialty gases, which are crucial for the scientific instrument industry. Companies in this sector need to closely monitor developments and strategically plan their procurement schedules [1][2]. Helium Supply Chain - Qatar is a major helium producer, accounting for approximately 30% of global production, with nearly all exports passing through the Strait of Hormuz. Helium is essential for the operation of high-end scientific instruments such as nuclear magnetic resonance machines and gas chromatography devices [3]. - Iran has a production capacity for neon gas, holding a global market share of about 15%-20%. Neon is a key raw material for scientific instruments [3]. Logistics and Transportation - If the Strait of Hormuz remains closed for an extended period, ships would need to reroute around the Cape of Good Hope, adding approximately 8-10 days to the Asia-Europe shipping route [8]. - This delay could affect the timely delivery of high-priority scientific instruments and components, particularly those related to biological sample testing and production line equipment [9]. - Some shipping companies have announced emergency surcharges due to the situation, leading to noticeable fluctuations in container shipping rates on the Asia-Europe route [9]. Industry Response and Adaptation - Companies are diversifying their procurement sources by establishing partnerships with multiple gas suppliers to mitigate risks. Domestic helium resource development is also underway, with companies like PetroChina and Sinopec building helium extraction facilities [10]. - Optimizing inventory management for critical materials like liquid helium and specialty gases is becoming standard practice, with companies maintaining safety stock and planning procurement 2-3 months in advance [10]. - The adoption of technologies such as zero-evaporation helium technology and helium recovery systems is progressing, which can reduce dependency on continuous helium supply [10]. Market Sentiment and Price Fluctuations - The market sentiment may lead to short-term price volatility for specialty gases, although actual supply impacts will depend on the duration of the current geopolitical tensions. If the closure of the Strait is temporary, the effects will be limited [6][10].

Core Viewpoint - The company, Leibotech, demonstrated strong resilience in its operations during the complex macroeconomic environment of 2025, maintaining profitability and achieving net profit growth despite a slight decline in total revenue [2][4]. Financial Performance - Total revenue for 2025 was 402.23 million yuan, a decrease of 5.14% compared to the previous year [3]. - Operating profit reached 45.61 million yuan, reflecting a year-on-year increase of 4.26% [3]. - Total profit amounted to 45.41 million yuan, up by 3.83% year-on-year [4]. - Net profit attributable to shareholders was 39.38 million yuan, showing a growth of 0.59% [4]. - The net profit excluding non-recurring gains and losses was 33.06 million yuan, with a significant increase of 6.77% [4]. - The overall gross profit margin for all products remained stable, consistent with the previous year [4]. Cost Management and Efficiency - The company effectively managed its overall cost and expense control, leading to a decrease in absolute amounts of various period expenses during the reporting period [4]. - Continuous optimization of production processes has been a focus, enhancing operational efficiency while controlling costs and ensuring product quality [5]. Industry Context and Strategic Shift - The modern laboratory faces unprecedented challenges, requiring more than just high-precision analytical instruments; a closed-loop solution covering sample preparation to final data output is essential [4]. - Leibotech is transitioning from merely manufacturing laboratory scientific instruments to becoming a full-process partner for laboratories, providing comprehensive solutions to address multidimensional research and testing challenges [5]. - The company is focusing on new material analysis, new energy detection, and new pollutant treatment as key areas for research and development, aiming to build core technological competitiveness [5]. - Sales strategies include enhancing team expertise, expanding industry applications, and actively developing new customers to deepen and expand market business [5].

Core Viewpoint - The implementation of 1,079 new standards starting from March 2026 will significantly enhance the depth and breadth of scientific instruments in key industries such as food, pharmaceuticals, chemicals, and metal mining, emphasizing their irreplaceable role in ensuring public safety, improving production efficiency, and promoting green transformation in industries [2][4]. Group 1: Food Industry - Scientific instruments have evolved from simple sensory detection to precise molecular identification, ensuring food safety from farm to table [4]. - New laboratory quality control standards for food physicochemical testing (GB/T 27404) and microbiological testing (GB/T 27405) demand higher sensitivity from instruments [4]. - Advanced techniques like High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) enable precise detection of trace substances in feed and cosmetics [5]. Group 2: Pharmaceutical Industry - The pharmaceutical sector relies heavily on scientific instruments, where data accuracy is critical for life safety [6]. - Updates to imaging diagnostic standards (WS/T 874, WS/T 873) enhance diagnostic capabilities in grassroots medical institutions [6]. - New standards for rapid nucleic acid testing instruments (GB/T 47026) highlight the importance of scientific instruments in responding to public health emergencies [6]. Group 3: Chemical Industry - The chemical industry is transitioning from extensive to refined and green practices, with scientific instruments acting as navigators [7]. - Techniques like X-ray fluorescence (XRF) and gas chromatography (GC) are crucial for analyzing multi-element content in industrial cooling water and detecting residual monomers in resins [7]. - Instruments such as differential scanning calorimeters (DSC) and tensile testing machines provide authoritative data for new material characterization [7]. Group 4: Geological and Mining Industry - Scientific instruments serve as a "telescope" for deep resource exploration and recycling in the metal and mining sectors [8]. - Scanning electron microscopes (SEM) and electron probe microanalysis (EPMA) standardize the analysis of mineral rock samples, revealing microscopic geological structures [8]. - High-pressure electrostatic separators and sulfur content measurement devices enhance resource conversion efficiency in metallurgy [9]. Group 5: New Standards Implementation - A total of 1,079 new standards will be implemented in March 2026, covering various sectors including food safety, pharmaceuticals, and environmental monitoring [10][11][12].